689 related articles for article (PubMed ID: 27682885)
21. Utility of Nontraditional Risk Markers in Individuals Ineligible for Statin Therapy According to the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines.
Yeboah J; Polonsky TS; Young R; McClelland RL; Delaney JC; Dawood F; Blaha MJ; Miedema MD; Sibley CT; Carr JJ; Burke GL; Goff DC; Psaty BM; Greenland P; Herrington DM
Circulation; 2015 Sep; 132(10):916-22. PubMed ID: 26224808
[TBL] [Abstract][Full Text] [Related]
22. Ten-Year Risk Equations for Incident Heart Failure in Established Atherosclerotic Cardiovascular Disease Populations.
Dawson LP; Carrington MJ; Haregu T; Nanayakkara S; Jennings G; Dart A; Stub D; Inouye M; Kaye D
J Am Heart Assoc; 2024 Jun; 13(11):e034254. PubMed ID: 38780153
[TBL] [Abstract][Full Text] [Related]
23. A 10- and 15-year performance analysis of ESC/EAS and ACC/AHA cardiovascular risk scores in a Southern European cohort.
Santos-Ferreira C; Baptista R; Oliveira-Santos M; Moura JP; Gonçalves L
BMC Cardiovasc Disord; 2020 Jun; 20(1):301. PubMed ID: 32560700
[TBL] [Abstract][Full Text] [Related]
24. Predicting 10-Year and Lifetime Stroke Risk in Chinese Population.
Xing X; Yang X; Liu F; Li J; Chen J; Liu X; Cao J; Shen C; Yu L; Lu F; Wu X; Zhao L; Li Y; Hu D; Lu X; Gu D
Stroke; 2019 Sep; 50(9):2371-2378. PubMed ID: 31390964
[TBL] [Abstract][Full Text] [Related]
25. Prediction of atherosclerotic cardiovascular disease mortality in a nationally representative cohort using a set of risk factors from pooled cohort risk equations.
Zhang Z; Gillespie C; Bowman B; Yang Q
PLoS One; 2017; 12(4):e0175822. PubMed ID: 28426694
[TBL] [Abstract][Full Text] [Related]
26. Risk Prediction Models for Atherosclerotic Cardiovascular Disease in Patients with Chronic Kidney Disease: The CRIC Study.
Bundy JD; Rahman M; Matsushita K; Jaeger BC; Cohen JB; Chen J; Deo R; Dobre MA; Feldman HI; Flack J; Kallem RR; Lash JP; Seliger S; Shafi T; Weiner SJ; Wolf M; Yang W; Allen NB; Bansal N; He J;
J Am Soc Nephrol; 2022 Mar; 33(3):601-611. PubMed ID: 35145041
[TBL] [Abstract][Full Text] [Related]
27. Prediction of the 10-year risk of atherosclerotic cardiovascular disease in the Korean population.
Park S; Kim YG; Ann SH; Cho YR; Kim SJ; Han S; Park GM
Epidemiol Health; 2023; 45():e2023052. PubMed ID: 37189276
[TBL] [Abstract][Full Text] [Related]
28. The Role of Sex-Specific Risk Factors in the Risk Assessment of Atherosclerotic Cardiovascular Disease for Primary Prevention in Women.
Freaney PM; Khan SS; Lloyd-Jones DM; Stone NJ
Curr Atheroscler Rep; 2020 Jul; 22(9):46. PubMed ID: 32671475
[TBL] [Abstract][Full Text] [Related]
29. Tea consumption and the risk of atherosclerotic cardiovascular disease and all-cause mortality: The China-PAR project.
Wang X; Liu F; Li J; Yang X; Chen J; Cao J; Wu X; Lu X; Huang J; Li Y; Zhao L; Shen C; Hu D; Yu L; Liu X; Wu X; Wu S; Gu D
Eur J Prev Cardiol; 2020 Dec; 27(18):1956-1963. PubMed ID: 31914807
[TBL] [Abstract][Full Text] [Related]
30. Development and Validation of a Risk Prediction Model for Atherosclerotic Cardiovascular Disease in Japanese Adults: The Hisayama Study.
Honda T; Chen S; Hata J; Yoshida D; Hirakawa Y; Furuta Y; Shibata M; Sakata S; Kitazono T; Ninomiya T
J Atheroscler Thromb; 2022 Mar; 29(3):345-361. PubMed ID: 33487620
[TBL] [Abstract][Full Text] [Related]
31. Performance of the pooled cohort equations in cancer survivors: the Atherosclerosis Risk in Communities study.
Polter EJ; Blaes A; Wolfson J; Lutsey PL; Florido R; Joshu CE; Guha A; Platz EA; Prizment A
J Cancer Surviv; 2024 Feb; 18(1):124-134. PubMed ID: 37140677
[TBL] [Abstract][Full Text] [Related]
32. Predictive value of 10-year atherosclerotic cardiovascular disease risk equations from the China-PAR for new-onset lower extremity peripheral artery disease.
He P; Fan F; Chen C; Liu B; Jia J; Sun P; Li J; Zhou J; Zhang Y
Front Cardiovasc Med; 2022; 9():933054. PubMed ID: 36267634
[TBL] [Abstract][Full Text] [Related]
33. Ambient PM2.5 and its components associated with 10-year atherosclerotic cardiovascular disease risk in Chinese adults.
Li J; Tang W; Li S; He C; Dai Y; Feng S; Zeng C; Yang T; Meng Q; Meng J; Pan Y; Deji S; Zhang J; Xie L; Guo B; Lin H; Zhao X;
Ecotoxicol Environ Saf; 2023 Sep; 263():115371. PubMed ID: 37643506
[TBL] [Abstract][Full Text] [Related]
34. [Accuracy of the China-PAR and WHO risk models in predicting the ten-year risks of cardiovascular disease in the Chinese population].
Chen WY; Liu XF; Shen P; Chen Q; Sun YX; Wu JG; Lu P; Zhang JY; Lin HB; Tang X; Gao P
Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Aug; 43(8):1275-1281. PubMed ID: 35981990
[No Abstract] [Full Text] [Related]
35. Validation of an Integrated Risk Tool, Including Polygenic Risk Score, for Atherosclerotic Cardiovascular Disease in Multiple Ethnicities and Ancestries.
Weale ME; Riveros-Mckay F; Selzam S; Seth P; Moore R; Tarran WA; Gradovich E; Giner-Delgado C; Palmer D; Wells D; Saffari A; Sivley RM; Lachapelle AS; Wand H; Clarke SL; Knowles JW; O'Sullivan JW; Ashley EA; McVean G; Plagnol V; Donnelly P
Am J Cardiol; 2021 Jun; 148():157-164. PubMed ID: 33675770
[TBL] [Abstract][Full Text] [Related]
36. Development and Validation of the CANHEART Population-Based Laboratory Prediction Models for Atherosclerotic Cardiovascular Disease.
Sud M; Sivaswamy A; Austin PC; Anderson TJ; Naimark DMJ; Farkouh ME; Lee DS; Roifman I; Thanassoulis G; Tu K; Udell JA; Wijeysundera HC; Ko DT
Ann Intern Med; 2023 Dec; 176(12):1638-1647. PubMed ID: 38079638
[TBL] [Abstract][Full Text] [Related]
37. Predicting cardiovascular disease risk across the atherosclerotic disease continuum.
Poppe KK; Wells S; Jackson R; Doughty RN; Kerr AJ
Eur J Prev Cardiol; 2022 Feb; 28(18):2010-2017. PubMed ID: 33624049
[TBL] [Abstract][Full Text] [Related]
38. Predictive validity of the ACC/AHA pooled cohort equations in predicting residual-specific mortality in a national prospective cohort study of adults in the United States.
Edwards MK; Addoh O; Loprinzi PD
Postgrad Med; 2016 Nov; 128(8):865-868. PubMed ID: 27701986
[TBL] [Abstract][Full Text] [Related]
39. Cardiovascular disease risk prediction equations in 400 000 primary care patients in New Zealand: a derivation and validation study.
Pylypchuk R; Wells S; Kerr A; Poppe K; Riddell T; Harwood M; Exeter D; Mehta S; Grey C; Wu BP; Metcalf P; Warren J; Harrison J; Marshall R; Jackson R
Lancet; 2018 May; 391(10133):1897-1907. PubMed ID: 29735391
[TBL] [Abstract][Full Text] [Related]
40. Primary Prevention With Statins: ACC/AHA Risk-Based Approach Versus Trial-Based Approaches to Guide Statin Therapy.
Mortensen MB; Afzal S; Nordestgaard BG; Falk E
J Am Coll Cardiol; 2015 Dec; 66(24):2699-2709. PubMed ID: 26700832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
